Clinical Trial Update: Bioequivalence Study to Compare Diclofenac Potassium Coated Tablet Versus Cataflam® 50 Coated Tablet [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/Phase 2 bioequivalence study comparing diclofenac potassium coated tablet to Cataflam 50 Coated Tablet has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Analgesic Indication
• Antipyretic Indication
• Non-steroidal Anti-inflammatory Disease

Drugs mentioned

• Cataflam 50 Coated Tablet (diclofenac potassium)
• Diclofenac potassium coated tablet (diclofenac potassium)

Snippet

Sponsor: Humanis Saglık Anonim Sirketi | Conditions: Non-steroidal Anti-inflammatory (NSAID), Analgesic | Phase 1, Phase 2 | Status: COMPLETED